Results 101 to 110 of about 75,755 (323)

Use of sodium‐glucose cotransporter‐2 inhibitors among older adults with type 2 diabetes mellitus in British Columbia

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Clinical guidelines recommend sodium‐glucose cotransporter‐2 inhibitors (SGLT2is) for individuals with type 2 diabetes mellitus (T2DM) and established or high risk of cardiorenal disease. This study examined real‐world SGLT2i use patterns among older adults with T2DM in British Columbia, Canada.
Hanin Harbi   +10 more
wiley   +1 more source

Variation between countries in the frequency of diabetic ketoacidosis at first presentation of type 1 diabetes in children: a systematic review [PDF]

open access: yes, 2012
AIMS/HYPOTHESIS: Type 1 diabetes is the most frequent endocrine disease in children, with 65,000 children diagnosed worldwide every year. Up to 80% of these children present with diabetic ketoacidosis (DKA), which is associated with both short-term risks
A. Ercole   +3 more
core   +3 more sources

Efficacy and safety of combining empagliflozin in people with type 2 diabetes mellitus uncontrolled with metformin and sitagliptin: A randomised, double‐blind, multicentre, therapeutic confirmatory phase 3 clinical trial

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aim This study evaluated the efficacy and safety of empagliflozin 10 and 25 mg compared to placebo as add‐on treatment for people with type 2 diabetes mellitus (T2DM) uncontrolled after ≥8 weeks of treatment with metformin and sitagliptin. Materials and Methods A randomised, double‐blind, multicentre, therapeutic confirmatory, phase 3 clinical
Seung‐Hwan Lee   +15 more
wiley   +1 more source

Serum Neuron-specific Enolase and S100 Calcium-binding Protein B in Pediatric Diabetic Ketoacidosis

open access: yesJCRPE, 2019
Objective:Neuron-specific enolase (NSE) and S100 calcium-binding protein B (S100B) are markers of different neurological disorders. The aim was to investigate the relationship between NSE and S100B serum concentrations and the severity of diabetic ...
Hatem Hamed Elshorbagy   +11 more
doaj   +1 more source

Issues in Diagnosis and Treatment of Type 1 Diabetes Mellitus in Childhood [PDF]

open access: yes, 2016
Type 1 Diabetes Mellitus remains one of the most complex chronic diseases in childhood. Although advances in knowledge and technology, as the use of insulin pumps or glucose sensors, have improved the quality of life of patients, the onset of the disease,
IUGHETTI, Lorenzo, Lucaccioni, Laura
core   +1 more source

In‐flight glycaemic control using automated insulin delivery systems: A within‐subject comparative pilot study

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Background Automated insulin delivery systems (AID) are increasingly used by people living with type 1 diabetes, but their functionality during air travel remains insufficiently studied. Some concerns have arisen regarding safety using AID systems under flight conditions, particularly related to potential insulin delivery errors induced by ...
Renald Meçani   +13 more
wiley   +1 more source

Treatment of Diabetic Ketoacidosis With Subcutaneous Insulin Aspart [PDF]

open access: bronze, 2004
Guillermo E. Umpierrez   +5 more
openalex   +1 more source

Independent associations of mental health and diabetes complications with health‐related quality of life: Evidence from a cross‐sectional study

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Health‐related quality of life (HRQoL) is a key patient‐reported outcome in diabetes care, yet the extent to which somatic and psychological factors are associated with HRQoL remains unclear. This study examined how demographic, diabetes‐related, medical, and psychological factors were independently associated with HRQoL in adults with ...
Norbert Hermanns   +4 more
wiley   +1 more source

Sodium–glucose cotransporter-2 inhibition and acidosis in patients with type 2 diabetes: a review of US FDA data and possible conclusions

open access: yesInternational Journal of Nephrology and Renovascular Disease, 2017
John A D’Elia,1 Alissa R Segal,1,2 George P Bayliss,3 Larry A Weinrauch1 1Kidney and Hypertension Section, Joslin Diabetes Center, Harvard Medical School, 2Department of Pharmacy Practice, MCPHS University, Boston, MA, 3Division of Kidney Diseases ...
D'Elia JA   +3 more
doaj  

Home - About - Disclaimer - Privacy